ArriVent BioPharma, Inc. 10-Q filing
Filed 2025-11-10 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001104659-25-108847
- Form type
- 10-Q
- CIK
- 0001868279
- Primary document
- https://www.sec.gov/Archives/edgar/data/1868279/000110465925108847/avbp-20250930x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ArriVent BioPharma, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-138.7M | - | - |
| Net Income | $-130.8M | - | - |
| Eps Basic | -3.54 | - | - |
| Eps Diluted | -3.54 | - | - |
| Cash And Equivalents | $112.7M | - | - |
| Total Assets | $326.6M | - | - |
| Total Liabilities | $21.6M | - | - |
| Shareholders Equity | $305.0M | - | - |
| Operating Cash Flow | $-129.9M | - | - |